127 related articles for article (PubMed ID: 38244730)
1. Ursodeoxycholic acid and 18β-glycyrrhetinic acid alleviate ethinylestradiol-induced cholestasis via downregulating RORγt and CXCR3 signaling pathway in iNKT cells.
Li X; Liang X; Gu X; Zou M; Cao W; Liu C; Wang X
Toxicol In Vitro; 2024 Apr; 96():105782. PubMed ID: 38244730
[TBL] [Abstract][Full Text] [Related]
2. iNKT17 cells play a pathogenic role in ethinylestradiol-induced cholestatic hepatotoxicity.
Kong W; Li X; Zou M; Zhang Y; Cai H; Zhang L; Wang X
Arch Toxicol; 2023 Feb; 97(2):561-580. PubMed ID: 36329302
[TBL] [Abstract][Full Text] [Related]
3. UDCA and CDCA alleviate 17α-ethinylestradiol-induced cholestasis through PKA-AMPK pathways in rats.
Li X; Yuan Z; Liu R; Hassan HM; Yang H; Sun R; Zhang L; Jiang Z
Toxicol Appl Pharmacol; 2016 Nov; 311():12-25. PubMed ID: 27743861
[TBL] [Abstract][Full Text] [Related]
4. 18β-Glycyrrhetinic acid protects against alpha-naphthylisothiocyanate-induced cholestasis through activation of the Sirt1/FXR signaling pathway.
Wu SY; Cui SC; Wang L; Zhang YT; Yan XX; Lu HL; Xing GZ; Ren J; Gong LK
Acta Pharmacol Sin; 2018 Dec; 39(12):1865-1873. PubMed ID: 30061734
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of 18β-glycyrrhetinic acid on pulmonary arterial hypertension via regulation of Rho A/Rho kinsase pathway.
Zhang M; Chang Z; Zhang P; Jing Z; Yan L; Feng J; Hu Z; Xu Q; Zhou W; Ma P; Hao Y; Zhou R
Chem Biol Interact; 2019 Sep; 311():108749. PubMed ID: 31325423
[TBL] [Abstract][Full Text] [Related]
6. Activation of natural killer T cells contributes to Th1 bias in the murine liver after 14 d of ethinylestradiol exposure.
Zou MZ; Kong WC; Cai H; Xing MT; Yu ZX; Chen X; Zhang LY; Wang XZ
World J Gastroenterol; 2022 Jul; 28(26):3150-3163. PubMed ID: 36051344
[TBL] [Abstract][Full Text] [Related]
7. Galactosylated Pro-Drug of Ursodeoxycholic Acid: Design, Synthesis, Characterization, and Pharmacological Effects in a Rat Model of Estrogen-Induced Cholestasis.
Di Guida F; Pirozzi C; Magliocca S; Santoro A; Lama A; Russo R; Nieddu M; Burrai L; Boatto G; Mollica MP; Sodano F; Lazzarato L; Chegaev K; Meli R; Raso GM; Rimoli MG
Mol Pharm; 2018 Jan; 15(1):21-30. PubMed ID: 29140706
[TBL] [Abstract][Full Text] [Related]
8. Lack of benefit of ursodeoxycholic acid in drug-induced cholestasis in the rat.
Hillstrom J; Duane WC; Eckfeldt JH; Furne J; Levitt MD
Proc Soc Exp Biol Med; 1992 May; 200(1):122-6. PubMed ID: 1570353
[TBL] [Abstract][Full Text] [Related]
9. Ursodeoxycholate Restores Biliary Excretion of Methotrexate in Rats with Ethinyl Estradiol Induced-Cholestasis by Restoring Canalicular Mrp2 Expression.
Kim MJ; Kang YJ; Kwon M; Choi YA; Choi MK; Chi HY; Yoo HH; Shim CK; Song IS
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642532
[TBL] [Abstract][Full Text] [Related]
10. 18β-Glycyrrhetinic acid inhibits IL-1β-induced inflammatory response in mouse chondrocytes and prevents osteoarthritic progression by activating Nrf2.
Chen B; Zhu D; Xie C; Shi Y; Ni L; Zhang H; Li S; Lu J; Xiao J; Xia W; Huang C; Wang X
Food Funct; 2021 Sep; 12(18):8399-8410. PubMed ID: 34369548
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate hepatotoxicity is associated with oxidative stress, and down-regulation of PPARγ and Nrf2: Protective effect of 18β-Glycyrrhetinic acid.
Mahmoud AM; Hussein OE; Hozayen WG; Abd El-Twab SM
Chem Biol Interact; 2017 May; 270():59-72. PubMed ID: 28414158
[TBL] [Abstract][Full Text] [Related]
12. 18β-glycyrrhetinic acid suppresses Lewis lung cancer growth through protecting immune cells from ferroptosis.
Ma X; Sun Z; Chen H; Cao L; Zhao S; Fan L; Zhao C; Yin S; Hu H
Cancer Chemother Pharmacol; 2024 Jun; 93(6):575-585. PubMed ID: 38383823
[TBL] [Abstract][Full Text] [Related]
13. 18β-Glycyrrhetinic acid induces human HaCaT keratinocytes apoptosis through ROS-mediated PI3K-Akt signaling pathway and ameliorates IMQ-induced psoriasis-like skin lesions in mice.
Gao J; Guo J; Nong Y; Mo W; Fang H; Mi J; Qi Q; Yang M
BMC Pharmacol Toxicol; 2020 Jun; 21(1):41. PubMed ID: 32493482
[TBL] [Abstract][Full Text] [Related]
14. 18β-Glycyrrhetinic acid mitigates radiation-induced skin damage via NADPH oxidase/ROS/p38MAPK and NF-κB pathways.
Su L; Wang Z; Huang F; Lan R; Chen X; Han D; Zhang L; Zhang W; Hong J
Environ Toxicol Pharmacol; 2018 Jun; 60():82-90. PubMed ID: 29677640
[TBL] [Abstract][Full Text] [Related]
15. 18β-Glycyrrhetinic acid ameliorates endoplasmic reticulum stress-induced inflammation in pulmonary arterial hypertension through PERK/eIF2α/NF-κB signaling.
Wang JL; Liu H; Jing ZC; Zhao F; Zhou R
Chin J Physiol; 2022; 65(4):187-198. PubMed ID: 36073567
[TBL] [Abstract][Full Text] [Related]
16. Hepatoprotection in ethinylestradiol-treated rats is provided by tauroursodeoxycholic acid, but not by ursodeoxycholic acid.
Azer SA; Canfield PJ; Stacey NH
J Gastroenterol Hepatol; 1995; 10(3):261-9. PubMed ID: 7548801
[TBL] [Abstract][Full Text] [Related]
17. 18β-glycyrrhetinic acid alleviates radiation-induced skin injury by activating the Nrf2/HO-1 signaling pathway.
Wang Z; Chen R; Chen J; Su L
Biol Chem; 2024 Jun; 405(6):407-415. PubMed ID: 38598859
[TBL] [Abstract][Full Text] [Related]
18. 18β-Glycyrrhetinic acid protects against methotrexate-induced kidney injury by up-regulating the Nrf2/ARE/HO-1 pathway and endogenous antioxidants.
Abd El-Twab SM; Hozayen WG; Hussein OE; Mahmoud AM
Ren Fail; 2016 Oct; 38(9):1516-1527. PubMed ID: 27499091
[TBL] [Abstract][Full Text] [Related]
19. 18β-glycyrrhetinic acid attenuates anandamide-induced adiposity and high-fat diet induced obesity.
Park M; Lee JH; Choi JK; Hong YD; Bae IH; Lim KM; Park YH; Ha H
Mol Nutr Food Res; 2014 Jul; 58(7):1436-46. PubMed ID: 24687644
[TBL] [Abstract][Full Text] [Related]
20. 18β-Glycyrrhetinic acid alleviates demyelination by modulating the microglial M1/M2 phenotype in a mouse model of cuprizone-induced demyelination.
Tian H; Cheng Y; Zhang Y; Bai X; Jiang Y; Li J; Fan S; Ding H
Neurosci Lett; 2021 Jun; 755():135871. PubMed ID: 33812928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
